Immunovia AB (publ)
Immunovia AB (publ) (IMMVF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IMMVF · as of Jun 9, 2026
Key Statistics
Explore Immunovia AB (publ) Data
immvf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
immvf competitorsIMMVF
ANPCY
ASAPF
CLCS
MBGNF
OPGNStock Performance
Full HistoryAbout Immunovia AB (publ)
Immunovia AB (publ) is a Swedish diagnostics firm that develops and commercializes blood tests for markets both within Sweden and worldwide. Its flagship product is IMMray PanCan-d, an innovative bloo…
what is immunovia ab (publ) · immvf stock overview · immunovia ab (publ) company profile · who is immunovia ab (publ) ceo · immvf OTC · immunovia ab (publ) headquarters · immunovia ab (publ) business segments
About Stock Overview & Key Data
Immunovia AB (publ) (IMMVF) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Jun 28, 2019. As of the latest trading session, IMMVF stock price is $0.02, with a market capitalization of $6.1M. The stock has returned -61.59% over the past 12 months and +0.00% year-to-date.
In fiscal year 2025, Immunovia AB (publ) reported revenue of $683281.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Immunovia AB (publ) (IMMVF) stock price is $0.02. The stock is traded on OTC under the ticker symbol IMMVF. The 52-week range is $0.02 – $0.15.